New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
... -- Masimo (Nasdaq: MASI ), the inventor of
pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion
pulse oximetry, announced today that three new ... the same sensor used with Masimo Rainbow SET(R)
pulse CO-Oximeters, it has the strong potential to ...
Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
... -- Masimo (Nasdaq: MASI ), the inventor of
pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion
pulse oximetry, announced today that two new studies - ... as part of the upgradeable Masimo Rainbow SET(R)
pulse CO-Oximetry platform.
(1) Bernard AC et al. ...
New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
... -- Masimo (Nasdaq: MASI ), the inventor of
pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion
pulse oximetry, announced today that a new independent ... and methemoglobin (SpMet) with Masimo Rainbow SET
pulse CO-Oximetry is accurate and may help clinicians ...
New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
... /PRNewswire-FirstCall/ -- Masimo, the inventor
of
pulse CO-Oximetry(TM) and Measure-Through Motion and ... may well be curative for this colleague."
New
pulse Oximetry Sensors with Low Saturation Accuracy ... Severe Methemoglobinemia Detected by
pulse CO-Oximetry in the Operating
Room(4), a case ...
New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
... -- Masimo (Nasdaq:
MASI), the inventor of
pulse CO-Oximetry and Read-Through Motion and Low
Perfusion
pulse oximetry, reported that a new independent and ... of the plethysmographic signal
displayed on the
pulse oximeter. In addition to improving the detection ...
FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents
... (26 percent), fatigue (18
percent), upper abdominal pain (14 percent), and sedation (13 percent).(11)
Small to modest changes in blood pressure,
pulse rate, and ECG parameters
were observed.(11)
About ADHD
ADHD is one of the most common psychiatric disorders in children ....
FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications
... recommended. Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic instability (irregular
pulse or blood pressure, tachycardia, diaphoresis and cardiac dysrhythmia). Additional signs may include elevated creatinine phosphokinase, myoglobinuria ...
Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
... in the clinical program. The majority of these cases occurred in the long-term, open label studies. Small to modest changes in blood pressure,
pulse rate, and ECG parameters were observed.
About ADHD
ADHD is one of the most common psychiatric disorders in children and adolescents. ...
Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session
... and commercially available in Europe and is currently under clinical investigation at major U.S. research and academic facilities. It consists of a
pulse generator and conventional pacing leads which deliver the therapy to the cardiac tissue. The device is implanted in a manner similar to a pacemaker ...
Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
... Journal of Hypertension , investigators measured 493 adult subjects participating in the Baltimore Longitudinal Study of Aging for their aortic
pulse wave velocity (an index of aortic stiffness) and CML (using Synvista's proprietary technology). Results demonstrated that elevated levels of CML in ...
Fralex provides update on timing of interim analysis results
... provided an update
on receiving results of the interim analysis for the RELIEF pivotal study.
The trial is investigating the use of Complex Neural
pulse or CNP(TM)
therapy for the relief of chronic pain associated with fibromyalgia.
The Independent Data Monitoring Committee ("DMC") is scheduled to ...
Can Implantable Devices for Heart Failure Help Assess Risk of Future Adverse Events for Heart Failure Patients?
... Additionally, if a potentially life-threatening arrhythmia is
detected, the devices in this study were capable of delivering an
electrical
pulse or shock to correct it.
Dr. Whellan explained that the trial observed how well the diagnostic
parameters predicted the incidence of clinical ....
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
... recommended. Clinical manifestations of NMS are
hyperpyrexia, muscle rigidity, altered mental status and evidence of
autonomic instability (irregular
pulse or blood pressure, tachycardia,
diaphoresis and cardiac dysrhythmia). Additional signs may include elevated
creatinine phosphokinase, myoglobinuria ...
Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market
... signal processing and the advancement of innovative pulse
oximeter products. With the introduction of the Onyx(R), the world's first
fingertip
pulse oximeter, Nonin Medical changed the global market for
oximetry. Today, Nonin Medical has the largest installed base of pulse
oximeters in the ...
Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
... size and weight of a hairdryer, works by placing it to the back of the head and pushing a button twice, sending a very brief magnetic field
pulse into the brain. The 16-site multicenter, randomized, double blind study is the first rigorous test of the magnetic stimulation device. -- ...
Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
... Clinical manifestations of NMS are hyperpyrexia, muscle
rigidity, altered mental status and evidence of autonomic instability
(irregular
pulse or blood pressure, tachycardia, diaphoresis and cardiac
dysrhythmia). Additional signs may include elevated creatinine
phosphokinase, myoglobinuria ...
BioElectronics Announces Major Clinical Trials
... BIEL), the maker of the ActiPatch(TM), a drug free anti-
inflammatory patch, with an embedded battery operated microchip delivering
continuous
pulse therapy specifically designed to speed healing, today
announced world renowned plastic surgeon David G. Genecov will develop,
institute and complete ...
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
... quetiapine. Clinical manifestations of NMS are
hyperpyrexia, muscle rigidity, altered mental status, and evidence of
autonomic instability (irregular
pulse or blood pressure, tachycardia,
diaphoresis, and cardiac dysrhythmia). Additional signs may include
elevated creatine phosphokinase, myoglobinuria ...
Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
... headache (26 percent), fatigue (18 percent), upper
abdominal pain (14 percent) and sedation (13 percent). Small to modest
changes in blood pressure,
pulse rate, and ECG parameters were observed.
About ADHD
ADHD is one of the most common psychiatric disorders in children and
adolescents. ...
New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
... quetiapine. Clinical manifestations of NMS are
hyperpyrexia, muscle rigidity, altered mental status, and evidence of
autonomic instability (irregular
pulse or blood pressure, tachycardia,
diaphoresis, and cardiac dysrhythmia). Additional signs may include
elevated creatine phosphokinase, myoglobinuria ...
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
... recommended. Clinical
manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental
status and evidence of autonomic instability (irregular
pulse or blood
pressure, tachycardia, diaphoresis and cardiac dysrhythmia). Additional
signs may include elevated creatinine phosphokinase, ...
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
... condition known as NMS has been reported with ABILIFY. NMS can cause hyperpyrexia, muscle rigidity, diaphoresis, tachycardia, irregular
pulse or blood pressure, cardiac dysrhythmia, and altered mental status. If signs and symptoms appear, immediate discontinuation is recommended
...
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
... recommended. Clinical
manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental
status and evidence of autonomic instability (irregular
pulse or blood
pressure, tachycardia, diaphoresis and cardiac dysrhythmia). Additional
signs may include elevated creatinine phosphokinase, ...
AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
... quetiapine. Clinical manifestations of NMS are
hyperpyrexia, muscle rigidity, altered mental status, and evidence of
autonomic instability (irregular
pulse or blood pressure, tachycardia,
diaphoresis, and cardiac dysrhythmia). Additional signs may include
elevated creatine phosphokinase, myoglobinuria ...
Vanderbilt Medical Center Seeks Middle Tennesseans with Type 2 Diabetes Who are Overweight for National Clinical Trial
... and are overweight. Impact on weight loss, blood pressure and
other clinical and metabolic parameters will also be studied.
TANTALUS includes a
pulse generator and leads that are implanted
through a minimally invasive laparoscopic procedure that can be performed
in an outpatient setting. The leads ...
Raydiance Collaborates With Rutgers University and Nation's Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
... About Raydiance, Inc. Raydiance, Inc. is the developer of the world's first compact, cost-
effective and fully software-controlled Ultrashort
pulse (USP) laser
system. This breakthrough technology platform harnesses the incredible
power and precision of these lasers and makes them easily ...
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
... quetiapine. Clinical manifestations of NMS are
hyperpyrexia, muscle rigidity, altered mental status, and evidence of
autonomic instability (irregular
pulse or blood pressure, tachycardia,
diaphoresis, and cardiac dysrhythmia). Additional signs may include
elevated creatine phosphokinase, myoglobinuria ...
Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
... (TR-LIFS), exploits the phenomenon that bi-products of
metabolic activity behave differently than surrounding tissue. In TR-LIFS,
a short light
pulse (picoseconds) is used to excite the tissue, and then
the resulting light that emanates from the tissue is monitored over a brief
time span (several ...
Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology
Shown to Significantly Lower Instances of Severe Retinopathy of
Prematurity in Extremely Low Birth Weight Infants
... 30, 2007 /PRNewswire/ -- Masimo, the
inventor of
pulse CO-Oximetry and Read-Through Motion and Low
Perfusion
pulse oximetry, reported that a new independent ... this month showed that switching to
Masimo SET
pulse oximetry technology can reduce the risk ...
New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release
Tablets as Effective Treatment for Schizophrenia
... mental status, and evidence of autonomic instability
(irregular
pulse or blood pressure, tachycardia, diaphoresis, and
cardiac dysrhythmia). ... mental status, and evidence of autonomic instability
(irregular
pulse or blood pressure, tachycardia, diaphoresis, and
cardiac dysrhythmia). ...
Shire Announces Positive Results of Studies With Guanfacine
Extended Release, An Investigational Nonstimulant Medication Filed
for the Treatment of ADHD in Children and Adolescents
... nausea (5.1 percent). Small to modest changes in blood
pressure,
pulse rate, and ECG were observed with GXR but were not
clinically meaningful.
... and hot environment).
While small changes in average blood pressure and
pulse rate
occurred, cardiovascular events were uncommon.
For all doses, the ...
Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with
Electroporation DNA Delivery Technology and New Devices at Gene
Therapy Meeting
... 1000 system, which recently received CE marking,
consists of an advanced
pulse generator and a two-needle DNA
injector that delivers the genes and electroporation pulses in a
single step. The
pulse generator allows flexible programming of
pulse and injection parameters ...
AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II
Study with Novel Cystic Fibrosis Therapy
... with 9 subjects aged 12-16 years (Phase
II). Safety and tolerability were assessed by spirometric
evaluation of pulmonary function, vital signs,
pulse oximetry,
physical examinations, clinical laboratory tests, electrocardiogram
(ECG), and by monitoring adverse events. Efficacy was assessed ...
MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study
of Aquavan Injection in Patients Undergoing Bronchoscopy
... was transient hypoxemia (defined as blood oxygen saturation
levels less than or equal to 90% for more than 30 seconds at any
point, as measured by
pulse oximetry), which was observed in 15% of
patients who received an initial bolus dose of 6.5 mg/kg of Aquavan
compared to 13% of patients who received ...
Interferon Beta DNA Treatment Delivered with Ichor Technology
Reduces Atherosclerosis Progression in Mice
... DNA administration. This system allows the
site of DNA injection, placement of electrodes, rate of DNA
administration and timing of electrical
pulse application to be
consistent among different operators and patients. As a result,
Ichor's TriGrid enables safe, effective and reproducible ...
Six-Week Investigational Study In Adults With Major Depressive
Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole
Therapy With Antidepressants
... known as NMS has
been reported with aripiprazole. NMS can cause hyperpyrexia, muscle
rigidity, diaphoresis, tachycardia, irregular
pulse or blood pressure,
cardiac dysrhythmia, and altered mental status. If signs and symptoms
appear, immediate discontinuation is ...
Investigational Study Evaluates the Effectiveness of Aripiprazole
in Adolescents With Schizophrenia
... known as NMS has
been reported with aripiprazole. NMS can cause hyperpyrexia, muscle
rigidity, diaphoresis, tachycardia, irregular
pulse or blood pressure,
cardiac dysrhythmia, and altered mental status. If signs and symptoms
appear, immediate discontinuation is ...
Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
... impedance to classify and count red and white blood cells based on their size. Improvements to the application of electrical impedance include
pulse editing, which corrects for cells passing through the aperture at various angles or at the same instant.
Cell counters must be sophisticated ...